<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>Key Technologies Research and Development Program</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><pagination>101313</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12409376</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(8)</volume><pubmed_abstract>P-glycoprotein (P-gp) is a transmembrane protein widely involved in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of drugs within the human body. Accurate prediction of P-gp inhibitors and substrates is crucial for drug discovery and toxicological assessment. However, existing models rely on limited molecular information, leading to suboptimal model performance for predicting P-gp inhibitors and substrates. To overcome this challenge, we compiled an extensive dataset from public databases and literature, consisting of 5,943 P-gp inhibitors and 4,018 substrates, notable for their high quantity, quality, and structural uniqueness. In addition, we curated two external test sets to validate the model's generalization capability. Subsequently, we developed a multimod</pubmed_abstract><journal>Journal of pharmaceutical analysis</journal><pubmed_title>A multimodal contrastive learning framework for predicting P-glycoprotein substrates and inhibitors.</pubmed_title><pmcid>PMC12409376</pmcid><funding_grant_id>2022YFF1203003</funding_grant_id><funding_grant_id>82373791</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Hou T</pubmed_authors><pubmed_authors>Kang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A multimodal contrastive learning framework for predicting P-glycoprotein substrates and inhibitors.</name><description>P-glycoprotein (P-gp) is a transmembrane protein widely involved in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of drugs within the human body. Accurate prediction of P-gp inhibitors and substrates is crucial for drug discovery and toxicological assessment. However, existing models rely on limited molecular information, leading to suboptimal model performance for predicting P-gp inhibitors and substrates. To overcome this challenge, we compiled an extensive dataset from public databases and literature, consisting of 5,943 P-gp inhibitors and 4,018 substrates, notable for their high quantity, quality, and structural uniqueness. In addition, we curated two external test sets to validate the model's generalization capability. Subsequently, we developed a multimod</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-03T07:08:07.345Z</modification><creation>2026-05-29T03:05:47.718Z</creation></dates><accession>S-EPMC12409376</accession><cross_references><pubmed>40919587</pubmed><doi>10.1016/j.jpha.2025.101313</doi></cross_references></HashMap>